← Back to Clinical Trials
Recruiting NCT07020546

NCT07020546 Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07020546
Status Recruiting
Phase —
Sponsor Generation Next Fertility
Condition Infertility
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2025-07-08
Primary Completion 2026-06-30

Trial Parameters

Condition Infertility
Sponsor Generation Next Fertility
Study Type INTERVENTIONAL
Phase N/A
Enrollment 180
Sex FEMALE
Min Age 18 Years
Max Age 47 Years
Start Date 2025-07-08
Completion 2026-06-30
Interventions
Ovarian Platelet-rich plasma (PRP) injections

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.

Eligibility Criteria

Inclusion Criteria: * No none contraindications to IVF or PRP treatment * Adequate ovarian reserves and AMH level * Willingness to undergo two IVF cycles and oPRP treatment Exclusion Criteria: * Anovulation due to menopause or perimenopause * Any health conditions that are contraindicated for IVF or oPRP treatment

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE INFERTILITY TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology